New Advances in Detection and Prevention of Cancer

Offered in Cooperation with the W. M. Keck Foundation, UCLA's Jonsson Comprehensive Cancer Center, UCLA Lung Cancer SPORE, David Geffen School of Medicine at UCLA, and UCLA Extension 

Tuesday, November 2, 2004
9:00 a.m.–4:30 p.m.
Covel Commons, Grand Horizon Room,

in Sunset Village on the UCLA Campus 

Symposium Homepage

9:00 a.m. Introduction—Leonard Rome, Ph.D.; Senior Associate Dean of Research, David Geffen School of Medicine at UCLA
9:05 a.m. Welcome and Opening Remarks—Steven M. Dubinett, M.D.
9:10 a.m.

 

 

 Molecular Targeted Preventive Drug Development—Scott M. Lippman, M.D.; Professor of Clinical Cancer Prevention; Chair, Clinical Cancer Prevention; Professor of Thoracic and Head & Neck Medical Oncology; The University of Texas M.D. Anderson Cancer Center
9:55 a.m.

 

 

 COX-2: A Molecular Target for Cancer Prevention—Andrew J. Dannenberg, M.D.; Henry R. Erle, M.D.-Roberts Family Professor of Medicine, Weill Medical College of Cornell University; Director of Cancer Prevention, NewYork-Presbyterian Hospital/Weill Cornell Medical Center
10:40 a.m. Break
10:55 a.m.

 

 Targets for Prevention and Treatment of Colorectal Cancer—Raymond N. DuBois, M.D.; Mina Cobb Wallace Professor; Chief, Division of Gastroenterology; Vanderbilt University Medical Center
11:40 a.m. Lunch
1:00 p.m.

 

 Imaging Based Lung Cancer Detection—Denise Aberle, M.D.; Professor of Radiological Sciences; Chief, Thoracic Imaging Section; UCLA
1:45 p.m.

 

 Shape-Encoded Particles for Multiplex Analyses—Stanley F. Nelson, M.D.; Associate Professor, Human Genetics and Psychiatry; Research Scientist, Center for Neurobehavioral Genetics; UCLA
2:30 p.m. Break
2:45 p.m.

 

 

 Early Diagnosis and Chemoprevention of Lung Cancer: New Molecular Approaches—Jonathan M. Kurie, M.D.; Associate Professor, Thoracic and Head & Neck Medical Oncology, The University of Texas M.D. Anderson Cancer Center
3:30 p.m.

 

 

 Chemoprevention of Breast Cancer: Proof of Principle—Patricia Ganz, M.D.; Professor, Schools of Medicine and Public Health; Director, Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center; UCLA
4:15 p.m. Closing Remarks—Steven M. Dubinett, M.D.
4:30 p.m. Symposium Concludes

UCLA Extension is approved by the California Board of Registered Nursing (BRN), provider number CEP 11952. This symposium is approved for 5.25 contact hours.